SOUTH SAN FRANCISCO, Calif., May 22, 2007 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
-- Friedman, Billings, Ramsey & Co. 2007 Growth Conference in New York
Wednesday, May 30th at 12:50 p.m. Eastern Time
-- Bank of America 2007 Healthcare Conference in Las Vegas
Thursday, May 31st at 4:00 p.m. Pacific Time
To access a webcast of the live events please visit Pain Therapeutics' web site, www.paintrials.com. A replay will also be available through June 31, 2007.
About Pain Therapeutics, Inc.
We develop novel drugs for pain management and hematology/oncology. We have three investigational drug candidates in clinical programs. Remoxy(tm) and PTI-202 are proprietary, abuse-resistant forms of opioid drugs. Oxytrex(tm) is a novel, next-generation painkiller that potentially offers less physical dependence than currently marketed opioid painkillers. Our early-stage drugs include a novel radio-labeled monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. We are also working on a new treatment for patients with hemophilia, a rare blood disorder. The FDA has not yet evaluated the merits, safety or efficacy of our drug candidates. For more information, please visit our website at www.paintrials.com.